Repligen Corp
RGEN· Nasdaq
RGENRepligen Corp
Filed Mar 15, 2013 · 10-K · 74 days after period end · 0001193125-13-109050
| Metric | Q4 2012 | Q4 2011 |
|---|---|---|
| Revenue | $18.81M | $7.17M |
| Net Income | $9.55M | -$2.16M |
| EPS Diluted | $0.30 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Mar 15, 2013 · 74 d after period end
